Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases.

MLA

Hofman, Jakub, et al. “Pharmacokinetic Interactions of Breast Cancer Chemotherapeutics with Human Doxorubicin Reductases.” Biochemical Pharmacology, vol. 96, no. 3, Aug. 2015, pp. 168–78. EBSCOhost, https://doi.org/10.1016/j.bcp.2015.05.005.

APA

Hofman, J., Skarka, A., Havrankova, J., & Wsol, V. (2015). Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases. Biochemical Pharmacology, 96(3), 168–178. https://doi.org/10.1016/j.bcp.2015.05.005

Chicago

Hofman, Jakub, Adam Skarka, Jana Havrankova, and Vladimir Wsol. 2015. “Pharmacokinetic Interactions of Breast Cancer Chemotherapeutics with Human Doxorubicin Reductases.” Biochemical Pharmacology 96 (3): 168–78. doi:10.1016/j.bcp.2015.05.005.